A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.

BACKGROUND

Blue light sources have been shown to be effective in the treatment of mild to moderate inflammatory acne vulgaris lesions.

OBJECTIVE

We evaluated the safety and efficacy of a new blue light source in the treatment of mild to moderate inflammatory acne vulgaris in comparison to topical 1% clindamycin solution.

RESULTS

Blue light therapy reduced inflammatory acne vulgaris lesions by an average of 34%, as compared to 14% for topical 1% clindamycin solution.

CONCLUSIONS

The blue light source presented in this report is a safe and effective treatment option available to our patients with mild to moderate inflammatory acne lesions.